SARS-CoV-2 makes multiple proteins to propagate. If these proteins can be safely and effectively targeted, then viral activity and replication can be inhibited, resulting in reduced disease severity. more...
Interrupt Proteins In silico
We can help if you want to rapidly discover how your existing compounds can interrupt your proteins of interest. Our novel quasi-quantum molecular simulation platform, BioTD Sim, allows us to do this quickly and effectively, providing you with a detailed interaction analysis. We also have in silico libraries of over 1,700 FDA approved molecules and over 2,500 herbal molecules packaged as simulation candidates.
If you have a protein and you want to quickly but effectively assess (i) a novel compound's or (ii) an existing compound's direct interaction potential with that protein, we can help.
BioTD Sim has been tried and tested on some of the fastest super-computing centers in the world - thus it can position you for rapid accurate results.
Rapid in silico discovery of protein interruption is our forte.
Merge Disparate Sciences
We merge high performance computation with quantum physics, bio-chemistry, computer vision, statistics and autonomous decision-making
We are a Massachusetts based bio-tech company offering state-of-the-art molecular discovery and design services. Drug repositioning and de-novo molecular design are our major focus areas. Contact us for an in-depth discussion on what we do and how it can help leap-frog your own molecular design and discovery efforts.
Assess and Manipulate Molecules
Analyze. Detect. Align. Split. Modify. Repeat
Our state-of-the-art highly-parallelized algorithms autonomously
Determine electron densities and shifts
Detect molecular spatial features
Detect molecular charge features
Detect and splits molecular sub-domains and sub-structures
Determine molecule state in varying physiological pH
